Hi all, I’ve been reflecting on the great data presented at this year’s ASH Annual Meeting and Exposition and wanted to share some of my…

Hi all, As Day 4 of the ASH Annual Meeting and Exposition concludes, I’d like to revisit some key studies from the previous days. Highlights…

Hi all, As day 3 of the 65th ASH Annual Meeting and Exposition unfolds, I’m excited to share some key chronic lymphocytic leukemia (CLL) abstracts.…

Hi all, I hope everyone is having a productive time at the 65th ASH Annual Meeting and Exposition! Today, I’d like to share some of…

Hi all, Happy ASH! I’m excited to share some of my favorite chronic lymphocytic leukemia (CLL) abstracts from the first day of the 65th ASH…

Hello everyone, This month, I want to bring your attention to an excellent review article on the cardiovascular toxicities associated with various BTK inhibitors (BTKi).…

Hello Everyone, This month I would like to highlight some pivotal findings from recent CLL research, particularly focusing on patients’ quality of life. The SEQUOIA…

Hey Everyone, I hope you’re all doing well. I wanted to share some exciting findings from recent studies shedding light on venetoclax resistance in CLL.…